The landscape of obesity treatment is rapidly evolving with the emergence of several innovative injectable therapies. Tirzepatide , Cagrilintide , a GLP-1/GIP/GCG triple agonist , and a GLP-1 receptor agonist https://nexaphresearchpeptides.com/blog/